Wang L - Search Results

1

Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist.

Pang X, Zhao Y, Song J, Kang D, Wu S, Wang L, Liu A, Du G. Pang X, et al. Among authors: wang l. Mol Med Rep. 2019 Aug;20(2):1103-1112. doi: 10.3892/mmr.2019.10306. Epub 2019 May 28. Mol Med Rep. 2019. PMID: 31173186 Free PMC article.

2

Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.

Pang X, Wang L, Kang D, Zhao Y, Wu S, Liu AL, Du GH. Pang X, et al. Among authors: wang l. Molecules. 2017 Jul 25;22(8):1246. doi: 10.3390/molecules22081246. Molecules. 2017. PMID: 28757552 Free PMC article.

3

DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.

Zhou D, Zhou W, Song JK, Feng ZY, Yang RY, Wu S, Wang L, Liu AL, Du GH. Zhou D, et al. Among authors: wang l. Acta Pharmacol Sin. 2016 Nov;37(11):1401-1412. doi: 10.1038/aps.2016.87. Epub 2016 Aug 8. Acta Pharmacol Sin. 2016. PMID: 27498773 Free PMC article.

4

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.

Wang DM, Feng B, Fu H, Liu AL, Wang L, Du GH, Wu S. Wang DM, et al. Among authors: wang l. Molecules. 2017 Jan 20;22(1):172. doi: 10.3390/molecules22010172. Molecules. 2017. PMID: 28117700 Free PMC article.

5

Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.

Pang X, Fu H, Yang S, Wang L, Liu AL, Wu S, Du GH. Pang X, et al. Among authors: wang l. Molecules. 2017 Jul 26;22(8):1254. doi: 10.3390/molecules22081254. Molecules. 2017. PMID: 28933746 Free PMC article.

6

DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss.

Zhou W, Lian WW, Yan R, Jia H, Xu LJ, Wang L, Liu AL, Du GH. Zhou W, et al. Among authors: wang l. Acta Pharmacol Sin. 2020 May;41(5):599-611. doi: 10.1038/s41401-019-0312-y. Epub 2019 Nov 4. Acta Pharmacol Sin. 2020. PMID: 31685977 Free PMC article.

7

Actinomycin D synergistically enhances the cytotoxicity of CDDP on KB cells by activating P53 via decreasing P53-MDM2 complex.

Wang L, Pang XC, Yu ZR, Yang SQ, Liu AL, Wang JH, Du GH. Wang L, et al. Among authors: wang jh. J Asian Nat Prod Res. 2017 Jun;19(6):630-643. doi: 10.1080/10286020.2017.1318853. Epub 2017 Apr 25. J Asian Nat Prod Res. 2017. PMID: 28440085

8

Research Progress of the Antiviral Bioactivities of Natural Flavonoids.

Wang L, Song J, Liu A, Xiao B, Li S, Wen Z, Lu Y, Du G. Wang L, et al. Nat Prod Bioprospect. 2020 Oct;10(5):271-283. doi: 10.1007/s13659-020-00257-x. Epub 2020 Sep 18. Nat Prod Bioprospect. 2020. PMID: 32948973 Free PMC article. Review.

9

FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer.

Wang J, Xu Y, Li L, Wang L, Yao R, Sun Q, Du G. Wang J, et al. Among authors: wang l. Cancer Med. 2017 Jan;6(1):275-287. doi: 10.1002/cam4.990. Epub 2016 Dec 28. Cancer Med. 2017. PMID: 28028927 Free PMC article.

10

Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway.

Wang L, Yu Z, Ren S, Song J, Wang J, Du G. Wang L, et al. Among authors: wang j. Biochim Biophys Acta Gen Subj. 2018 Oct;1862(10):2281-2292. doi: 10.1016/j.bbagen.2018.07.017. Epub 2018 Jul 20. Biochim Biophys Acta Gen Subj. 2018. PMID: 30036603

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147,402 results

Search Page

Filters